Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized Pilot Study of the Effect of Sorafenib Dosing Schedule on Tolerability and Drug Delivery

NCT01203787 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT01203787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01203787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized Pilot Study of the Effect of Sorafenib Dosing Schedule on Tolerability and Drug Delivery
Lead sponsor
University of Florida
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2010
Completion date
March 31, 2014
Enrollment
120 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma